ECSP066942A - Procedimiento para la preparacion de derivados de tetralina sustituida e indano sustituido - Google Patents
Procedimiento para la preparacion de derivados de tetralina sustituida e indano sustituidoInfo
- Publication number
- ECSP066942A ECSP066942A EC2006006942A ECSP066942A ECSP066942A EC SP066942 A ECSP066942 A EC SP066942A EC 2006006942 A EC2006006942 A EC 2006006942A EC SP066942 A ECSP066942 A EC SP066942A EC SP066942 A ECSP066942 A EC SP066942A
- Authority
- EC
- Ecuador
- Prior art keywords
- substituted
- preparation
- indanoed
- procedure
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
- C07C303/04—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups
- C07C303/08—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups by reaction with halogenosulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/26—Separation; Purification; Stabilisation; Use of additives
- C07C319/28—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
La presente invención se refiere a un nuevo procedimiento para la preparación de derivados de tetralina sustituida e indano sustituido; la presente invención está dirigida además a nuevos procedimientos para la preparación de intermediarios en la preparación de los derivados de tetralina sustituida e indano sustituido.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56415904P | 2004-04-21 | 2004-04-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP066942A true ECSP066942A (es) | 2006-12-20 |
Family
ID=34967583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2006006942A ECSP066942A (es) | 2004-04-21 | 2006-10-20 | Procedimiento para la preparacion de derivados de tetralina sustituida e indano sustituido |
Country Status (20)
Country | Link |
---|---|
US (3) | US20050240049A1 (es) |
EP (1) | EP1745016A1 (es) |
JP (1) | JP2007534690A (es) |
KR (1) | KR20060133107A (es) |
CN (1) | CN101018766A (es) |
AR (1) | AR048931A1 (es) |
AU (1) | AU2005238485A1 (es) |
BR (1) | BRPI0510118A (es) |
CA (1) | CA2564558A1 (es) |
CR (1) | CR8757A (es) |
EA (1) | EA200601927A1 (es) |
EC (1) | ECSP066942A (es) |
IL (1) | IL178521A0 (es) |
MX (1) | MXPA06012288A (es) |
NI (1) | NI200600247A (es) |
NO (1) | NO20065341L (es) |
TW (1) | TW200606139A (es) |
UA (1) | UA85589C2 (es) |
WO (1) | WO2005105737A1 (es) |
ZA (1) | ZA200609613B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA009554B1 (ru) * | 2002-10-21 | 2008-02-28 | Янссен Фармацевтика Н.В. | Замещённые тетралины и инданы и их применение |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU632809B2 (en) | 1989-05-25 | 1993-01-14 | Takeda Chemical Industries Ltd. | Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof |
US5143713A (en) | 1990-05-30 | 1992-09-01 | Board Of Regents, The University Of Texas System | 99m Tc labeled liposomes |
ATE187436T1 (de) | 1993-08-06 | 1999-12-15 | Upjohn Co | 2-aminoindane als selektive dopamin-d3-liganden |
GB9606805D0 (en) * | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
GB9822473D0 (en) * | 1998-10-16 | 1998-12-09 | Glaxo Group Ltd | Chemical compounds |
CA2410647C (en) * | 2000-05-29 | 2010-02-09 | Kyorin Pharmaceutical Co., Ltd. | Substituted phenylpropanoic acid derivatives |
PL361162A1 (en) | 2000-10-05 | 2004-09-20 | Bayer Aktiengesellschaft | Propionic acid derivatives with ppar-alpha activating properties |
TWI241190B (en) | 2001-02-13 | 2005-10-11 | Aventis Pharma Gmbh | 4-Fluoro-N-indan-2-yl benzamide and its use as pharmaceutical |
JP2004520397A (ja) * | 2001-02-15 | 2004-07-08 | ファイザー・プロダクツ・インク | 増殖性アクチベータ受容体(ppar)化合物 |
EP1360172A1 (en) | 2001-02-15 | 2003-11-12 | Pfizer Products Inc. | Ppar agonists |
US7348334B2 (en) * | 2001-04-09 | 2008-03-25 | Dr. Reddy's Laboratories Limited | Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
US6548538B2 (en) * | 2001-05-22 | 2003-04-15 | Bayer Aktiengesellschaft | Propionic acid derivatives |
EP1399426A2 (en) * | 2001-06-12 | 2004-03-24 | Active Pass Pharmaceuticals, Inc. | Compounds, compositions and methods for modulating beta-amyloid production |
CA2502661A1 (en) * | 2002-10-21 | 2004-05-06 | Janssen Pharmaceutica, N.V. | Substituted tetralins and indanes |
US20060247314A1 (en) * | 2002-10-21 | 2006-11-02 | Xiaoli Chen | Substituted tetralins and indanes |
EA009554B1 (ru) * | 2002-10-21 | 2008-02-28 | Янссен Фармацевтика Н.В. | Замещённые тетралины и инданы и их применение |
US20060094786A1 (en) * | 2002-10-21 | 2006-05-04 | Xiaoli Chen | Treating syndrome X with substituted tetralins and indanes |
WO2004037777A1 (en) * | 2002-10-21 | 2004-05-06 | Janssen Pharmaceutica, N.V. | Treating syndrome x with substituted tetralins and indanes |
-
2005
- 2005-04-19 AR ARP050101529A patent/AR048931A1/es not_active Application Discontinuation
- 2005-04-20 EA EA200601927A patent/EA200601927A1/ru unknown
- 2005-04-20 WO PCT/US2005/013870 patent/WO2005105737A1/en active Application Filing
- 2005-04-20 CA CA002564558A patent/CA2564558A1/en not_active Abandoned
- 2005-04-20 TW TW094112498A patent/TW200606139A/zh unknown
- 2005-04-20 EP EP05741687A patent/EP1745016A1/en not_active Withdrawn
- 2005-04-20 BR BRPI0510118-2A patent/BRPI0510118A/pt not_active Application Discontinuation
- 2005-04-20 US US11/110,459 patent/US20050240049A1/en not_active Abandoned
- 2005-04-20 MX MXPA06012288A patent/MXPA06012288A/es not_active Application Discontinuation
- 2005-04-20 JP JP2007509684A patent/JP2007534690A/ja active Pending
- 2005-04-20 KR KR1020067023822A patent/KR20060133107A/ko not_active Application Discontinuation
- 2005-04-20 UA UAA200611177A patent/UA85589C2/ru unknown
- 2005-04-20 CN CNA2005800206126A patent/CN101018766A/zh active Pending
- 2005-04-20 AU AU2005238485A patent/AU2005238485A1/en not_active Abandoned
-
2006
- 2006-10-15 IL IL178521A patent/IL178521A0/en unknown
- 2006-10-16 NI NI200600247A patent/NI200600247A/es unknown
- 2006-10-20 EC EC2006006942A patent/ECSP066942A/es unknown
- 2006-11-20 ZA ZA2006/09613A patent/ZA200609613B/en unknown
- 2006-11-20 CR CR8757A patent/CR8757A/es not_active Application Discontinuation
- 2006-11-21 NO NO20065341A patent/NO20065341L/no not_active Application Discontinuation
-
2007
- 2007-12-18 US US11/958,618 patent/US7576238B2/en active Active
-
2009
- 2009-07-13 US US12/501,833 patent/US20090326258A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NI200600247A (es) | 2007-07-24 |
IL178521A0 (en) | 2007-02-11 |
JP2007534690A (ja) | 2007-11-29 |
CN101018766A (zh) | 2007-08-15 |
NO20065341L (no) | 2007-01-18 |
CA2564558A1 (en) | 2005-11-10 |
BRPI0510118A (pt) | 2007-09-25 |
CR8757A (es) | 2008-11-24 |
US20090326258A1 (en) | 2009-12-31 |
AR048931A1 (es) | 2006-06-14 |
EA200601927A1 (ru) | 2007-04-27 |
US7576238B2 (en) | 2009-08-18 |
AU2005238485A1 (en) | 2005-11-10 |
UA85589C2 (ru) | 2009-02-10 |
EP1745016A1 (en) | 2007-01-24 |
KR20060133107A (ko) | 2006-12-22 |
US20080096962A1 (en) | 2008-04-24 |
WO2005105737A1 (en) | 2005-11-10 |
TW200606139A (en) | 2006-02-16 |
MXPA06012288A (es) | 2007-03-15 |
ZA200609613B (en) | 2008-04-30 |
US20050240049A1 (en) | 2005-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP078032A (es) | Modificaciones cristalinas de la piraclostrobina | |
CY1122580T1 (el) | Χημικη συνθεση χρησιμη ως ενδιαμεσο για την παρασκευη ενος αναστολεα κατεχολ-ο-μεθυλοτρανσφερασης | |
BRPI0514361A (pt) | processo para a produção de dihidropteridinonas | |
ECSP078055A (es) | Formas sólidas cristalinas de tigeciclina y métodos para preparar las mismas | |
CR8357A (es) | Derivados de tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorio | |
CL2012000302A1 (es) | Compuestos derivados de tubulisinas; compuestos conjugados que los comprenden; compuestos intermediarios; y uso para tratar el cancer. | |
ECSP077321A (es) | Procesos e intermediarios para preparar inhibidores de cisteína proteasa | |
CL2008001823A1 (es) | Procedimiento de preparacion de rifaximina amorfa que comprende disolver rifaximina cruda en etanol absoluto caliente y posterior precipitacion por enfriamiento de la solucion. | |
CR9014A (es) | Novedosos derivados de heteroarilsulfamida benzofusionados como agentes anticonvulsionantes | |
CR9723A (es) | Nueva forma cristalina de un derivado de piridazino[4,5-b] indol | |
ECSP10010129A (es) | Inhibidores de quinasas símil polo | |
ECSP099296A (es) | Inmuno-reguladores, preparaciones y composiciones que incluyen los inmuno-reguladores, pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y métodos | |
CL2008001835A1 (es) | Uso de compuestos derivados de guaninas policiclicas para tratar la inflamacion; compuestos derivados de guanina; y compocicion farmaceutica que los comprende. | |
AR058253A1 (es) | Procedimiento para la preparacion de ferri-succinilcaseina | |
PA8577201A1 (es) | 3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b | |
HN2008000088A (es) | Heterociclicos de 1,4-dihidropiridina- fusionada, procesos para preparar los mismos, su uso y las composiciones que los contienen. | |
UY31990A (es) | Nuevos derivados | |
UY29434A1 (es) | Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como inhibidores de la inflamacinn | |
ECSP077306A (es) | Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparación y su uso como antiinflamatorios | |
ECSP099070A (es) | Bencilaminas, un proceso para su producción y su uso como agentes anti-inflamatorios | |
GT200500139A (es) | Metodo para la preparacion de acidos hidroxamicos | |
CO6551754A2 (es) | 7-[3.5-dihidroxi-2-(3-hidrixi-5-fenil-pent-1-enil)- ciclopentil] -n-etil-hept-5-enamida(bimatoprost) en forma cristalina ii, mètodos para la preparaciòn y mètodo para su uso | |
CO2024000890A2 (es) | Compuestos de heteroarilo para tratar la enfermedad de huntington | |
DOP2006000257A (es) | Derivados de 9-cloro-15-desoxiprostaglandina, procesos para su preparación y su uso como medicamento | |
ECSP066942A (es) | Procedimiento para la preparacion de derivados de tetralina sustituida e indano sustituido |